Wearing a face mask is certainly not an iron-clad guarantee that you won’t get sick – viruses can also transmit through the eyes and tiny viral particles, known as aerosols, can penetrate masks. However, masks are effective at capturing droplets, which is a main transmission route of coronavirus, and some studies have estimated a roughly fivefold protection versus no barrier alone (although others have found lower levels of effectiveness).

If you are likely to be in close contact with someone infected, a mask cuts the chance of the disease being passed on. If you’re showing symptoms of coronavirus, or have been diagnosed, wearing a mask can also protect others. Wearing a mask is NOT a substitute for Self-Isolation or staying at home. So masks are crucial for health and social care workers looking after patients and are also recommended for family members who need to care for someone who is ill – ideally both the patient and carer should have a mask.

Wear your mask when leaving home to go to work, essential shopping or for medical care. STAYING HOME STILL YOUR BEST PROTECTION AGAINST THE VIRUS !!

Source: thegaurdian.com

All viruses accumulate mutations over time and the virus that causes Covid-19 is no different. How widespread different strains of a virus become depends on natural selection – the versions that can propagate quickest and replicate effectively in the body will be the most “successful”. This doesn’t necessarily mean most dangerous for people though, as viruses that kill people rapidly or make them so sick that they are incapacitated may be less likely to be transmitted.

Genetic analysis by Chinese scientists of 103 samples of the virus, taken from patients in Wuhan and other cities, suggests that early on two main strains emerged, designated L and S. Although the L strain appeared to be more prevalent than the S strain (about 70% of the samples belonged to the former), the S branch of the virus was found to be the ancestral version.

The team behind this research suggested that this may indicate the L strain is more “aggressive”, either transmitting more easily or replicating faster inside the body. However, this theory is speculative at this stage – there haven’t yet been direct comparisons to see whether people who catch one version of the virus are more likely to pass it on or suffer more severe symptoms.

Source: thegaurdian.com

Many individuals who get coronavirus will experience nothing worse than seasonal flu symptoms, but the overall profile of the disease, including its mortality rate, looks more serious. At the start of an outbreak the apparent mortality rate can be an overestimate if a lot of mild cases are being missed. But Bruce Aylward, a WHO expert, who led an international mission to China to learn about the virus and the country’s response, said this has not been the case with Covid-19. The evidence did not suggest that we were only seeing the tip of the iceberg. If borne out by further testing, this could mean that current estimates of a roughly 1% fatality rate are accurate. This would make Covid-19 about 10 times more deadly than seasonal flu, which is estimated to kill between 290,000 and 650,000 people a year globally.

Source: thegaurdian.com

Most people who are not elderly and do not have underlying health conditions will not become critically ill from Covid-19. But the illness still has a higher chance of leading to serious respiratory symptoms than seasonal flu and there are other at-risk groups – health workers, for instance, are more vulnerable because they are likely to have higher exposure to the virus. The actions that young, healthy people take, including reporting symptoms and following quarantine instructions, will have an important role in protecting the most vulnerable in society and in shaping the overall trajectory of the outbreak.

Source: thegaurdian.com

Scientists were quick out of the gates in beginning development of a vaccine for the new coronavirus, helped by the early release of the genetic sequence by Chinese researchers. The development of a viable vaccine continues apace, with several teams now testing candidates in animal experiments. However, the incremental trials required before a commercial vaccine could be rolled out are still a lengthy undertaking – and an essential one to ensure that even rare side-effects are spotted. A commercially available vaccine within a year would be quick.

Source: thegaurdian.com